SODIUM THIOSULFATE

SODIUM THIOSULFATE was reported 560 times

SODIUM THIOSULFATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GUM NEOPLASM MALIGNANT STAGE UNSPECIFIED 2 0.3333
1 EXTENSIVE INTERDIALYTIC WEIGHT GAIN 1 0.2000
2 TRIGEMINAL NERVE PARESIS 2 0.1053
3 CYLINDRURIA 1 0.1000
4 BLOOD CYANIDE INCREASED 1 0.0556
5 SERUM COLOUR ABNORMAL 1 0.0500
6 CALCIPHYLAXIS 89 0.0485
7 TRIGEMINAL PALSY 2 0.0435
8 LARYNGEAL NECROSIS 2 0.0417
9 ALCALIGENES INFECTION 1 0.0417
10 VASCULAR RESISTANCE PULMONARY INCREASED 3 0.0349
11 INFUSION SITE NERVE DAMAGE 1 0.0312
12 TORULOPSIS INFECTION 1 0.0278
13 CUTANEOUS CALCIFICATION 5 0.0273
14 FLAP NECROSIS 1 0.0270
15 OSTEORADIONECROSIS 6 0.0270
16 HYPERPARATHYROIDISM TERTIARY 2 0.0267
17 SPINAL CORD INJURY CERVICAL 6 0.0238
18 CHORDAE TENDINAE RUPTURE 2 0.0204
19 CENTRAL VISION LOSS 4 0.0179
20 CLINICAL TRIAL PARTICIPANT 1 0.0175
21 BILIRUBIN URINE PRESENT 2 0.0168
22 CERVICAL CORD COMPRESSION 5 0.0138
23 TONGUE NECROSIS 1 0.0137
24 PYONEPHROSIS 1 0.0120
25 SKIN TEMPERATURE INCREASED 1 0.0118
26 ANGIODERMATITIS 1 0.0118
27 HEPATOBLASTOMA 1 0.0103
28 PROPIONIBACTERIUM INFECTION 1 0.0093
29 CRYSTAL DEPOSIT INTESTINE 2 0.0093
30 DRUG-DEVICE INTERACTION 1 0.0090
31 COLD FLASH 1 0.0086
32 MYOCARDIAL CALCIFICATION 1 0.0085
33 NECROTISING FASCIITIS STREPTOCOCCAL 1 0.0084
34 PSEUDOPOLYP 3 0.0083
35 FOREIGN BODY REACTION 2 0.0081
36 ERGOT POISONING 1 0.0080
37 RENAL REPLACEMENT THERAPY 1 0.0078
38 PULMONARY CALCIFICATION 3 0.0073
39 PROTEIN S DECREASED 1 0.0068
40 DEVICE RELATED BACTERAEMIA 2 0.0065
41 CALCINOSIS 13 0.0058
42 INFLUENZA B VIRUS TEST POSITIVE 1 0.0055
43 HAEMOFILTRATION 1 0.0053
44 CHEMICAL PERITONITIS 1 0.0051
45 BILIARY CIRRHOSIS 1 0.0050
46 BREAST NECROSIS 1 0.0048
47 PROTEUS TEST POSITIVE 1 0.0045
48 ECG SIGNS OF MYOCARDIAL ISCHAEMIA 1 0.0044
49 SOFT TISSUE NECROSIS 3 0.0044
50 VASCULAR PSEUDOANEURYSM RUPTURED 1 0.0043
51 MYOCARDIAL NECROSIS 1 0.0043
52 ESCHAR 3 0.0041
53 PATIENT DISSATISFACTION WITH DEVICE 1 0.0040
54 PURPURA FULMINANS 1 0.0039
55 CULTURE WOUND POSITIVE 1 0.0038
56 HAEMOSIDEROSIS 1 0.0037
57 PRODUCT INFORMATION CONTENT COMPLAINT 1 0.0036
58 POSTOPERATIVE ILEUS 2 0.0035
59 LARYNGEAL STENOSIS 2 0.0035
60 GENITAL PARAESTHESIA 1 0.0034
61 CORONARY ARTERY EMBOLISM 1 0.0034
62 BLOOD CREATINE DECREASED 1 0.0033
63 FALSE POSITIVE INVESTIGATION RESULT 3 0.0030
64 ANION GAP DECREASED 1 0.0029
65 DERMATOMYOSITIS 7 0.0028
66 LIVIDITY 1 0.0027
67 DIET NONCOMPLIANCE 1 0.0027
68 AXILLARY VEIN THROMBOSIS 1 0.0027
69 CARBON DIOXIDE DECREASED 3 0.0026
70 SKIN TURGOR DECREASED 1 0.0026
71 BLOOD KETONE BODY INCREASED 2 0.0026
72 LICHENIFICATION 1 0.0024
73 USE OF ACCESSORY RESPIRATORY MUSCLES 1 0.0024
74 SKIN INDURATION 5 0.0024
75 NEPHROGENIC SYSTEMIC FIBROSIS 7 0.0023
76 ANION GAP INCREASED 3 0.0022
77 TRANSPLANT DYSFUNCTION 4 0.0022
78 CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS 1 0.0022
79 URINARY TRACT INFECTION ENTEROCOCCAL 2 0.0021
80 SKIN NECROSIS 11 0.0021
81 SKIN FIBROSIS 1 0.0021
82 MYOGLOBINURIA 1 0.0019
83 VASCULAR CALCIFICATION 2 0.0019
84 METABOLIC ALKALOSIS 3 0.0019
85 JOINT CONTRACTURE 2 0.0019
86 PRODUCT CLOSURE ISSUE 1 0.0018
87 BLOOD FIBRINOGEN DECREASED 2 0.0018
88 RADIATION SKIN INJURY 2 0.0017
89 PULMONARY INFARCTION 4 0.0017
90 CARDIAC DEATH 2 0.0017
91 MEDICAL DEVICE SITE INFECTION 1 0.0016
92 HYPERNATRAEMIA 8 0.0016
93 SERUM SICKNESS-LIKE REACTION 1 0.0016
94 BLOOD PARATHYROID HORMONE ABNORMAL 1 0.0016
95 ANION GAP 1 0.0016
96 DRY GANGRENE 1 0.0016
97 GLUCOSE URINE PRESENT 2 0.0016
98 MITRAL VALVE CALCIFICATION 1 0.0016
99 MAGNETIC RESONANCE IMAGING HEAD ABNORMAL 1 0.0015
100 RENAL VEIN THROMBOSIS 1 0.0015
101 DERMATITIS DIAPER 1 0.0014
102 MONOCYTE PERCENTAGE INCREASED 1 0.0014
103 ALCOHOL INTOLERANCE 1 0.0014
104 CRYOGLOBULINAEMIA 1 0.0014
105 GASTRIC MUCOSAL LESION 1 0.0014
106 CLOSTRIDIUM TEST POSITIVE 3 0.0014
107 PARATHYROID TUMOUR BENIGN 1 0.0013
108 SERRATIA INFECTION 1 0.0013
109 SUPERINFECTION 2 0.0013
110 BREAKTHROUGH PAIN 3 0.0013
111 ENDOCARDITIS BACTERIAL 1 0.0013
112 SUPERINFECTION BACTERIAL 1 0.0013
113 PNEUMONIA MYCOPLASMAL 1 0.0013
114 SKIN BACTERIAL INFECTION 1 0.0012
115 LEUKOCYTURIA 1 0.0012
116 PULMONARY NOCARDIOSIS 1 0.0012
117 PERITONEAL DIALYSIS 1 0.0012
118 FACIAL PARALYSIS 10 0.0012
119 PSEUDOMONAL BACTERAEMIA 1 0.0012
120 CHOREA 2 0.0012
121 INTESTINAL PSEUDO-OBSTRUCTION 1 0.0011
122 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 3 0.0011
123 THROMBOCYTOSIS 4 0.0011
124 ENTEROCOLITIS INFECTIOUS 1 0.0011
125 INJECTION SITE ULCER 1 0.0011
126 INFECTED SKIN ULCER 2 0.0011
127 BLOOD PARATHYROID HORMONE INCREASED 3 0.0010
128 CONTINUOUS HAEMODIAFILTRATION 1 0.0010
129 STRIDOR 3 0.0010
130 CATHETER RELATED INFECTION 1 0.0010
131 METABOLIC ACIDOSIS 31 0.0010
132 OEDEMA MUCOSAL 1 0.0010
133 LIPODYSTROPHY ACQUIRED 2 0.0009
134 IRON OVERLOAD 1 0.0009
135 INFUSION SITE MASS 1 0.0009
136 PSEUDOMEMBRANOUS COLITIS 2 0.0009
137 GASTRIC POLYPS 2 0.0009
138 SUDDEN CARDIAC DEATH 3 0.0009
139 SUBCLAVIAN VEIN THROMBOSIS 1 0.0009
140 CORTISOL DECREASED 1 0.0009
141 ALLODYNIA 1 0.0009
142 HICCUPS 7 0.0009
143 PROCALCITONIN INCREASED 1 0.0009
144 COCCIDIOIDOMYCOSIS 1 0.0008
145 INFUSION SITE WARMTH 1 0.0008
146 BLOOD ELECTROLYTES ABNORMAL 1 0.0008
147 INJECTION SITE ABSCESS 2 0.0008
148 INFUSION SITE IRRITATION 1 0.0008
149 DRUG CLEARANCE DECREASED 1 0.0008
150 ABNORMAL SLEEP-RELATED EVENT 1 0.0008
151 LOW TURNOVER OSTEOPATHY 3 0.0008
152 HYPERLACTACIDAEMIA 2 0.0007
153 CYSTITIS NONINFECTIVE 1 0.0007
154 LYMPHOCYTE PERCENTAGE DECREASED 1 0.0007
155 GASTROINTESTINAL INJURY 2 0.0007
156 TONGUE DRY 1 0.0007
157 PERITONEAL CLOUDY EFFLUENT 1 0.0007
158 MACULE 2 0.0007
159 HAEMODIALYSIS 6 0.0007
160 PSEUDOMONAS INFECTION 6 0.0007
161 DIVERTICULUM INTESTINAL 3 0.0007
162 PNEUMONIA PNEUMOCOCCAL 1 0.0007
163 INFUSION SITE INDURATION 1 0.0007
164 HAEMORRHAGIC TRANSFORMATION STROKE 1 0.0007
165 SUSPECTED OFF LABEL USE 3 0.0007
166 ATRIOVENTRICULAR BLOCK SECOND DEGREE 2 0.0007
167 MULTIPLE-DRUG RESISTANCE 2 0.0006
168 PRODUCT DEPOSIT 1 0.0006
169 SKIN TIGHTNESS 3 0.0006
170 FUNGAEMIA 1 0.0006
171 HYPOCALCAEMIA 12 0.0006
172 OVARIAN CANCER RECURRENT 1 0.0006
173 ANTIPHOSPHOLIPID SYNDROME 1 0.0006
174 COLON CANCER METASTATIC 1 0.0006
175 CARDIOVASCULAR INSUFFICIENCY 1 0.0006
176 HYPERVOLAEMIA 3 0.0006
177 ENTEROBACTER INFECTION 1 0.0006
178 BLOOD PH DECREASED 1 0.0006
179 SNEEZING 13 0.0006
180 BLOOD CHLORIDE INCREASED 1 0.0006
181 VASCULAR PSEUDOANEURYSM 1 0.0006
182 SPINAL CORD INJURY 1 0.0006
183 INFUSION SITE DISCHARGE 1 0.0006
184 FIBRIN D DIMER INCREASED 2 0.0006
185 VOCAL CORD PARALYSIS 1 0.0006
186 CHEILITIS 3 0.0006
187 DEVICE ALARM ISSUE 1 0.0006
188 CEREBRAL VENOUS THROMBOSIS 1 0.0006
189 SOFT TISSUE INFECTION 1 0.0005
190 INFUSION SITE PAIN 7 0.0005
191 PNEUMOPERITONEUM 1 0.0005
192 PUPILLARY REFLEX IMPAIRED 1 0.0005
193 RETINOPATHY 2 0.0005
194 LUPUS NEPHRITIS 1 0.0005
195 NASAL OBSTRUCTION 1 0.0005
196 PARANASAL SINUS DISCOMFORT 2 0.0005
197 HAEMODYNAMIC INSTABILITY 4 0.0005
198 NEUROTOXICITY 9 0.0005
199 GANGRENE 3 0.0005
200 PERIPHERAL ISCHAEMIA 2 0.0005
201 HYPERPARATHYROIDISM 1 0.0005
202 CAPILLARY LEAK SYNDROME 1 0.0005
203 PULSELESS ELECTRICAL ACTIVITY 2 0.0005
204 POOR PERIPHERAL CIRCULATION 2 0.0005
205 SKIN HYPERPIGMENTATION 4 0.0005
206 SKIN ULCER 12 0.0005
207 INFUSION SITE BRUISING 1 0.0005
208 COMPLICATIONS OF TRANSPLANTED KIDNEY 1 0.0004
209 METHAEMOGLOBINAEMIA 1 0.0004
210 ROSACEA 2 0.0004
211 PAPULE 3 0.0004
212 ESCHERICHIA BACTERAEMIA 1 0.0004
213 PUSTULE 1 0.0004
214 LONG QT SYNDROME 1 0.0004
215 GASTROINTESTINAL TOXICITY 2 0.0004
216 PANNICULITIS 1 0.0004
217 HYPOPHOSPHATAEMIA 3 0.0004
218 DEVICE INFUSION ISSUE 1 0.0004
219 RENAL FAILURE CHRONIC 3 0.0004
220 ENDOCARDITIS 2 0.0004
221 AORTIC ARTERIOSCLEROSIS 1 0.0004
222 MULTIPLE ORGAN DYSFUNCTION SYNDROME 11 0.0004
223 HYPERSENSITIVITY VASCULITIS 1 0.0004
224 SHOCK HAEMORRHAGIC 3 0.0004
225 RED BLOOD CELL SEDIMENTATION RATE INCREASED 4 0.0004
226 MALNUTRITION 4 0.0004
227 NEPHROPATHY TOXIC 4 0.0004
228 SKIN HYPERTROPHY 1 0.0004
229 TUMOUR HAEMORRHAGE 1 0.0004
230 VOMITING PROJECTILE 1 0.0003
231 UPPER RESPIRATORY TRACT CONGESTION 1 0.0003
232 HAEMOTHORAX 1 0.0003
233 STRESS CARDIOMYOPATHY 2 0.0003
234 DEVICE POWER SOURCE ISSUE 1 0.0003
235 THORACIC VERTEBRAL FRACTURE 1 0.0003
236 BRAIN HERNIATION 1 0.0003
237 PROTHROMBIN TIME PROLONGED 2 0.0003
238 DERMATITIS 7 0.0003
239 METABOLIC ENCEPHALOPATHY 1 0.0003
240 OROPHARYNGEAL DISCOMFORT 3 0.0003
241 HYPERCAPNIA 1 0.0003
242 DUODENITIS 1 0.0003
243 FIBROSIS 1 0.0003
244 LARYNGEAL OEDEMA 2 0.0003
245 PORTAL HYPERTENSION 1 0.0003
246 HYPERCALCAEMIA 4 0.0003
247 BRAIN DEATH 1 0.0003
248 INFUSION SITE HAEMORRHAGE 1 0.0003
249 CARDIAC FAILURE ACUTE 2 0.0003
250 SKIN MASS 2 0.0003
251 CEREBRAL HAEMATOMA 1 0.0003
252 COLITIS ISCHAEMIC 2 0.0003
253 HEPATIC CYST 1 0.0003
254 ECCHYMOSIS 2 0.0003
255 SKIN LESION 8 0.0003
256 WOUND COMPLICATION 1 0.0003
257 REGURGITATION 1 0.0003
258 LARGE INTESTINE POLYP 2 0.0003
259 HYPERTRANSAMINASAEMIA 2 0.0003
260 NECROTISING FASCIITIS 1 0.0003
261 RETCHING 6 0.0003
262 LEUKOCYTOSIS 5 0.0003
263 CAROTID ARTERY OCCLUSION 1 0.0003
264 WOUND INFECTION 3 0.0003
265 VENTRICULAR ARRHYTHMIA 1 0.0003
266 PARADOXICAL DRUG REACTION 1 0.0003
267 WOUND HAEMORRHAGE 1 0.0003
268 BLOOD CALCIUM DECREASED 3 0.0003
269 CARDIOPULMONARY FAILURE 1 0.0003
270 THERAPY PARTIAL RESPONDER 4 0.0003
271 WOUND SECRETION 1 0.0003
272 TORSADE DE POINTES 2 0.0003
273 POLYURIA 2 0.0002
274 EXTRAVASATION 1 0.0002
275 ESCHERICHIA INFECTION 2 0.0002
276 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
277 LEG AMPUTATION 1 0.0002
278 AORTIC DISSECTION 1 0.0002
279 DERMATITIS ALLERGIC 3 0.0002
280 SENSATION OF FOREIGN BODY 2 0.0002
281 SKIN PLAQUE 2 0.0002
282 PULMONARY TUBERCULOSIS 1 0.0002
283 PRODUCT CONTAINER ISSUE 2 0.0002
284 OCULAR ICTERUS 1 0.0002
285 SKIN SWELLING 2 0.0002
286 MONOPLEGIA 1 0.0002
287 MUCOSAL INFLAMMATION 6 0.0002
288 IMMOBILE 1 0.0002
289 PARONYCHIA 1 0.0002
290 DRUG ERUPTION 4 0.0002
291 RESPIRATORY RATE INCREASED 2 0.0002
292 WHEELCHAIR USER 1 0.0002
293 JOINT RANGE OF MOTION DECREASED 3 0.0002
294 ANAL INCONTINENCE 2 0.0002
295 NEUTROPHIL COUNT DECREASED 9 0.0002
296 HAEMOGLOBIN INCREASED 1 0.0002
297 LUMBAR VERTEBRAL FRACTURE 1 0.0002
298 TINNITUS 10 0.0002
299 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
300 MENTAL STATUS CHANGES 6 0.0002
301 NEPHROGENIC ANAEMIA 1 0.0002
302 ARTERIOSCLEROSIS 2 0.0002
303 PULSE ABSENT 1 0.0002
304 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
305 ENTEROCOCCAL INFECTION 1 0.0002
306 SEPSIS 23 0.0002
307 NEURALGIA 5 0.0002
308 GASTROENTERITIS 3 0.0002
309 RENAL CELL CARCINOMA 1 0.0002
310 ENCEPHALOPATHY 5 0.0002
311 ERYSIPELAS 1 0.0002
312 CELLULITIS 10 0.0002
313 STOMATITIS 12 0.0002
314 AMMONIA INCREASED 1 0.0002
315 DEVICE RELATED INFECTION 3 0.0002
316 ELECTROCARDIOGRAM QT PROLONGED 7 0.0002
317 CACHEXIA 1 0.0002
318 PERIPHERAL VASCULAR DISORDER 1 0.0002
319 UNRESPONSIVE TO STIMULI 5 0.0002
320 POOR VENOUS ACCESS 2 0.0002
321 BRAIN FOG 3 0.0002
322 SERUM FERRITIN INCREASED 1 0.0002
323 BEHAVIOUR DISORDER 1 0.0002
324 STAPHYLOCOCCAL INFECTION 6 0.0002
325 GASTRIC ULCER HAEMORRHAGE 1 0.0002
326 INTRACRANIAL PRESSURE INCREASED 1 0.0002
327 SKIN INFECTION 2 0.0002
328 MITRAL VALVE INCOMPETENCE 2 0.0002
329 OFF LABEL USE 154 0.0002
330 SCAB 2 0.0002
331 VISUAL DISTURBANCE 1 0.0002
332 SKIN DISCOLOURATION 8 0.0002
333 HERPES VIRUS INFECTION 1 0.0002
334 URINE ODOUR ABNORMAL 1 0.0002
335 BACTERAEMIA 2 0.0002
336 THIRST 3 0.0002
337 CHOLECYSTITIS 2 0.0002
338 MYOCLONUS 2 0.0002
339 BLOOD POTASSIUM DECREASED 5 0.0002
340 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 9 0.0002
341 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
342 CHOLANGITIS 1 0.0002
343 SEPTIC SHOCK 7 0.0002
344 PNEUMONIA ASPIRATION 4 0.0002
345 INFUSION SITE SWELLING 1 0.0002
346 BRAIN OEDEMA 2 0.0002
347 SCREAMING 1 0.0002
348 HYPOPHAGIA 4 0.0002
349 PROCTALGIA 1 0.0002
350 ERUCTATION 3 0.0002
351 TENDON DISORDER 1 0.0002
352 PRODUCT PREPARATION ISSUE 1 0.0002
353 CHOLECYSTITIS CHRONIC 1 0.0001
354 FULL BLOOD COUNT DECREASED 3 0.0001
355 PALLOR 4 0.0001
356 CROHN'S DISEASE 1 0.0001
357 JOINT EFFUSION 1 0.0001
358 RESPIRATORY DISTRESS 4 0.0001
359 LYMPHOEDEMA 1 0.0001
360 LARGE INTESTINE PERFORATION 1 0.0001
361 AUTOIMMUNE HEPATITIS 1 0.0001
362 HUNGER 2 0.0001
363 LEUKOPENIA 7 0.0001
364 IMPAIRED QUALITY OF LIFE 2 0.0001
365 C-REACTIVE PROTEIN INCREASED 5 0.0001
366 INTENTIONAL UNDERDOSE 1 0.0001
367 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
368 MOUTH HAEMORRHAGE 1 0.0001
369 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
370 THERAPY NON-RESPONDER 6 0.0001
371 PANCREATITIS ACUTE 3 0.0001
372 TROPONIN INCREASED 1 0.0001
373 ACIDOSIS 1 0.0001
374 DISSOCIATION 1 0.0001
375 INTERCEPTED PRODUCT ADMINISTRATION ERROR 1 0.0001
376 AFFECTIVE DISORDER 1 0.0001
377 FURUNCLE 1 0.0001
378 RENAL CYST 1 0.0001
379 ULCER 2 0.0001
380 ATRIAL FLUTTER 1 0.0001
381 SENSORY DISTURBANCE 2 0.0001
382 MUSCLE TIGHTNESS 2 0.0001
383 ASPHYXIA 1 0.0001
384 OSTEONECROSIS 4 0.0001
385 HYPERAESTHESIA 1 0.0001
386 VENTRICULAR TACHYCARDIA 2 0.0001
387 TREATMENT FAILURE 10 0.0001
388 INFUSION SITE ERYTHEMA 1 0.0001
389 HAEMATEMESIS 3 0.0001
390 SCAR 2 0.0001
391 ANURIA 1 0.0001
392 HYPOACUSIS 5 0.0001
393 BLOOD MAGNESIUM DECREASED 1 0.0001
394 NEOPLASM PROGRESSION 4 0.0001
395 VOMITING 54 0.0001
396 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
397 URINE OUTPUT DECREASED 1 0.0001
398 BLOOD CALCIUM INCREASED 1 0.0001
399 TUMOUR LYSIS SYNDROME 1 0.0001
400 GRIP STRENGTH DECREASED 1 0.0001
401 COLD SWEAT 2 0.0001
402 PRODUCT COMMUNICATION ISSUE 1 0.0001
403 NAUSEA 88 0.0001
404 CHILLS 13 0.0001
405 LIMB INJURY 3 0.0001
406 PATHOGEN RESISTANCE 1 0.0001
407 RETINAL DETACHMENT 1 0.0001
408 UROSEPSIS 1 0.0001
409 HEPATIC CIRRHOSIS 2 0.0001
410 BLOOD SODIUM DECREASED 2 0.0001
411 HAEMATOTOXICITY 1 0.0001
412 PROTEINURIA 2 0.0001
413 EYE INFLAMMATION 1 0.0001
414 SINUS BRADYCARDIA 1 0.0001
415 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
416 BODY TEMPERATURE DECREASED 1 0.0001
417 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
418 HAEMATOCRIT DECREASED 2 0.0001
419 GASTROINTESTINAL DISORDER 9 0.0001
420 HYPOTONIA 1 0.0001
421 DRY THROAT 1 0.0001
422 BLINDNESS 4 0.0001
423 EAR DISCOMFORT 1 0.0001
424 CARDIAC ARREST 8 0.0001
425 INFLAMMATION 5 0.0001
426 CARDIO-RESPIRATORY ARREST 4 0.0001
427 SCRATCH 1 0.0001
428 HALLUCINATION, VISUAL 2 0.0001
429 SUDDEN DEATH 1 0.0001
430 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
431 IMPAIRED HEALING 3 0.0001
432 RASH PAPULAR 2 0.0001
433 INTESTINAL PERFORATION 1 0.0001
434 CHROMATURIA 2 0.0001
435 HAEMOGLOBIN DECREASED 9 0.0001
436 ERYTHEMA 18 0.0001
437 GASTRIC DISORDER 3 0.0001
438 SHOCK 2 0.0001
439 HYPOKALAEMIA 4 0.0001
440 ELECTROLYTE IMBALANCE 1 0.0001
441 HYPOXIA 3 0.0001
442 POLYNEUROPATHY 1 0.0001
443 SKIN EXFOLIATION 7 0.0001
444 NO THERAPEUTIC RESPONSE 1 0.0001
445 CEREBRAL INFARCTION 2 0.0001
446 INJECTION SITE EXTRAVASATION 1 0.0001
447 ABNORMAL WEIGHT GAIN 1 0.0001
448 GENERALISED OEDEMA 1 0.0001
449 POISONING 1 0.0001
450 COLITIS 3 0.0001
451 BLOOD PRESSURE INCREASED 12 0.0001
452 MYDRIASIS 1 0.0001
453 SEIZURE 9 0.0001
454 ROTATOR CUFF SYNDROME 1 0.0001
455 ANAPHYLACTIC SHOCK 2 0.0001
456 ORAL CANDIDIASIS 1 0.0001
457 BLOOD PRESSURE DECREASED 5 0.0001
458 PAIN OF SKIN 2 0.0001
459 BLOOD BILIRUBIN INCREASED 2 0.0001
460 SINUS CONGESTION 1 0.0001
461 IMPAIRED GASTRIC EMPTYING 1 0.0001
462 PERIPHERAL COLDNESS 1 0.0001
463 RESPIRATORY ARREST 2 0.0001
464 DEVICE OCCLUSION 1 0.0001
465 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
466 DIALYSIS 1 0.0001
467 RECTAL HAEMORRHAGE 3 0.0001
468 CARDIOGENIC SHOCK 1 0.0001
469 LETHARGY 4 0.0001
470 HYPERTHYROIDISM 1 0.0001
471 CONDITION AGGRAVATED 21 0.0001
472 FLUID OVERLOAD 1 0.0001
473 NASAL CONGESTION 4 0.0001
474 RENAL FAILURE 9 0.0001
475 SKIN HAEMORRHAGE 1 0.0001
476 PULMONARY OEDEMA 3 0.0001
477 THROAT IRRITATION 3 0.0001
478 HYPOAESTHESIA ORAL 1 0.0001
479 HEPATIC FAILURE 2 0.0001
480 NEUTROPENIA 9 0.0001
481 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
482 FEELING HOT 4 0.0001
483 LIMB DISCOMFORT 2 0.0001
484 ACUTE MYELOID LEUKAEMIA 1 0.0001
485 CYANOSIS 1 0.0001
486 COMA 3 0.0001
487 RESPIRATORY TRACT CONGESTION 1 0.0001
488 ABSCESS 1 0.0001
489 CARDIAC FAILURE 5 0.0001
490 BLOOD POTASSIUM INCREASED 1 0.0001
491 CHOLELITHIASIS 2 0.0001
492 TREMOR 10 0.0001
493 BLOOD UREA INCREASED 1 0.0001
494 FACE OEDEMA 1 0.0001
495 CANDIDA INFECTION 1 0.0001
496 MULTI-ORGAN FAILURE 1 0.0001
497 OEDEMA PERIPHERAL 7 0.0001
498 ECZEMA 3 0.0001
499 LOCAL SWELLING 1 0.0001
500 RASH MACULAR 2 0.0001
501 BURNING SENSATION 4 0.0001
502 HYPERKALAEMIA 2 0.0001
503 LYMPHOCYTE COUNT DECREASED 1 0.0001
504 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
505 ISCHAEMIC STROKE 1 0.0001
506 DECREASED APPETITE 13 0.0001
507 SYNOVITIS 1 0.0001
508 INFECTION 8 0.0001
509 OSTEOMYELITIS 1 0.0001
510 RESPIRATORY FAILURE 4 0.0001
511 HYPOTENSION 11 0.0001
512 TREATMENT NONCOMPLIANCE 3 0.0001
513 END STAGE RENAL DISEASE 1 0.0001
514 RESTLESSNESS 2 0.0001
515 PRURITUS 21 0.0001
516 ARTHROPATHY 3 0.0001
517 HEPATIC STEATOSIS 1 0.0001
518 BACTERIAL INFECTION 1 0.0001
519 SWELLING 5 0.0001
520 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
521 DYSPNOEA EXERTIONAL 2 0.0001
522 DEHYDRATION 7 0.0001
523 FEELING JITTERY 1 0.0001
524 SLEEP APNOEA SYNDROME 1 0.0001
525 PULMONARY FIBROSIS 1 0.0001
526 CHOLESTASIS 1 0.0001
527 POST PROCEDURAL COMPLICATION 1 0.0001
528 DRUG PRESCRIBING ERROR 1 0.0001
529 ACUTE RESPIRATORY FAILURE 1 0.0001
530 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
531 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
532 SKIN FISSURES 1 0.0001
533 DISEASE PROGRESSION 6 0.0001
534 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
535 SINUS DISORDER 1 0.0001
536 BLOOD PRESSURE ABNORMAL 1 0.0001
537 THROMBOSIS 4 0.0000
538 FEEDING DISORDER 1 0.0000
539 DRY MOUTH 4 0.0000
540 TASTE DISORDER 1 0.0000
541 DISCOMFORT 3 0.0000
542 BODY TEMPERATURE INCREASED 1 0.0000
543 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
544 PERITONITIS 1 0.0000
545 ABDOMINAL DISTENSION 5 0.0000
546 OSTEOARTHRITIS 2 0.0000
547 PLATELET COUNT DECREASED 5 0.0000
548 LOSS OF CONSCIOUSNESS 6 0.0000
549 IMPAIRED WORK ABILITY 1 0.0000
550 HYPERHIDROSIS 6 0.0000
551 RHINORRHOEA 3 0.0000
552 PRURITUS GENERALISED 1 0.0000
553 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
554 PRODUCT DISPENSING ERROR 1 0.0000
555 ACUTE KIDNEY INJURY 7 0.0000
556 FEBRILE NEUTROPENIA 3 0.0000
557 TOOTH DISORDER 1 0.0000
558 RASH MACULO-PAPULAR 1 0.0000
559 GLOSSODYNIA 1 0.0000
560 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
561 HEART RATE IRREGULAR 1 0.0000
562 PERICARDIAL EFFUSION 1 0.0000
563 DRUG INEFFECTIVE 57 0.0000
564 DYSPHAGIA 4 0.0000
565 DISEASE RECURRENCE 2 0.0000
566 RASH ERYTHEMATOUS 2 0.0000
567 MOBILITY DECREASED 3 0.0000
568 BLOOD PRESSURE FLUCTUATION 1 0.0000
569 TOXICITY TO VARIOUS AGENTS 7 0.0000
570 DRUG INTOLERANCE 4 0.0000
571 LOCALISED INFECTION 1 0.0000
572 PRESYNCOPE 1 0.0000
573 DYSPEPSIA 4 0.0000
574 ABASIA 1 0.0000
575 OSTEONECROSIS OF JAW 1 0.0000
576 HEART RATE INCREASED 4 0.0000
577 PRODUCT USE IN UNAPPROVED INDICATION 10 0.0000
578 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
579 UNEVALUABLE EVENT 3 0.0000
580 ABDOMINAL PAIN LOWER 1 0.0000
581 CARDIOVASCULAR DISORDER 1 0.0000
582 FLUID RETENTION 2 0.0000
583 HEPATITIS 1 0.0000
584 PARAESTHESIA 6 0.0000
585 GASTRITIS 1 0.0000
586 BRADYCARDIA 2 0.0000
587 PYREXIA 13 0.0000
588 JAUNDICE 1 0.0000
589 THROAT TIGHTNESS 1 0.0000
590 OEDEMA 2 0.0000
591 FEELING COLD 1 0.0000
592 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
593 WOUND 1 0.0000
594 PAIN IN JAW 1 0.0000
595 FLATULENCE 2 0.0000
596 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
597 RED BLOOD CELL COUNT DECREASED 1 0.0000
598 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
599 BALANCE DISORDER 3 0.0000
600 DYSSTASIA 1 0.0000
601 DYSPHONIA 2 0.0000
602 ASCITES 1 0.0000
603 LABORATORY TEST ABNORMAL 1 0.0000
604 PSYCHOTIC DISORDER 1 0.0000
605 APHASIA 1 0.0000
606 LACRIMATION INCREASED 1 0.0000
607 THERAPEUTIC RESPONSE DECREASED 2 0.0000
608 PLEURAL EFFUSION 2 0.0000
609 EPILEPSY 1 0.0000
610 ADVERSE EVENT 3 0.0000
611 FEMUR FRACTURE 1 0.0000
612 NERVOUS SYSTEM DISORDER 1 0.0000
613 PRODUCT USE ISSUE 6 0.0000
614 DRUG-INDUCED LIVER INJURY 1 0.0000
615 DRUG INTERACTION 5 0.0000
616 HEADACHE 19 0.0000
617 INFUSION RELATED REACTION 2 0.0000
618 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
619 FUNGAL INFECTION 1 0.0000
620 SKIN DISORDER 1 0.0000
621 NEOPLASM MALIGNANT 2 0.0000
622 RASH 13 0.0000
623 ABDOMINAL DISCOMFORT 5 0.0000
624 SOMNOLENCE 6 0.0000
625 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
626 ANGER 1 0.0000
627 FLUSHING 3 0.0000
628 HAEMATURIA 1 0.0000
629 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
630 ANXIETY 8 0.0000
631 PAIN 17 0.0000
632 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
633 CONSTIPATION 6 0.0000
634 HYPERGLYCAEMIA 1 0.0000
635 MUSCLE SPASMS 5 0.0000
636 AGITATION 2 0.0000
637 DYSURIA 1 0.0000
638 DYSGEUSIA 2 0.0000
639 THROMBOCYTOPENIA 3 0.0000
640 HYPOAESTHESIA 4 0.0000
641 FATIGUE 20 0.0000
642 DISORIENTATION 1 0.0000
643 COUGH 7 0.0000
644 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
645 DYSKINESIA 1 0.0000
646 DIZZINESS 12 0.0000
647 RENAL IMPAIRMENT 2 0.0000
648 RENAL FAILURE ACUTE 1 0.0000
649 DYSPNOEA 13 0.0000
650 PRODUCT STORAGE ERROR 2 0.0000
651 MUSCULOSKELETAL STIFFNESS 2 0.0000
652 ANGIOEDEMA 1 0.0000
653 DRY SKIN 3 0.0000
654 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
655 DEATH 19 0.0000
656 VISION BLURRED 3 0.0000
657 DIARRHOEA 14 0.0000
658 OROPHARYNGEAL PAIN 2 0.0000
659 HYPERSENSITIVITY 4 0.0000
660 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
661 ARRHYTHMIA 1 0.0000
662 PULMONARY EMBOLISM 2 0.0000
663 MIGRAINE 2 0.0000
664 ATRIAL FIBRILLATION 2 0.0000
665 LUNG DISORDER 1 0.0000
666 ALOPECIA 4 0.0000
667 PAIN IN EXTREMITY 6 0.0000
668 CHEST DISCOMFORT 2 0.0000
669 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
670 HOSPITALISATION 3 0.0000
671 THERAPY CESSATION 1 0.0000
672 PERIPHERAL SWELLING 3 0.0000
673 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
674 HAEMORRHAGE 2 0.0000
675 DEPRESSED MOOD 1 0.0000
676 HYPERTENSION 4 0.0000
677 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
678 ASTHENIA 7 0.0000
679 DRUG EFFECT DECREASED 1 0.0000
680 CONFUSIONAL STATE 3 0.0000
681 PNEUMONIA 6 0.0000
682 ANAPHYLACTIC REACTION 1 0.0000
683 INFLUENZA 2 0.0000
684 URTICARIA 3 0.0000
685 HYPONATRAEMIA 1 0.0000
686 EYE PAIN 1 0.0000
687 MUSCULAR WEAKNESS 2 0.0000
688 INCORRECT DOSE ADMINISTERED 4 0.0000
689 HERPES ZOSTER 1 0.0000
690 EYE IRRITATION 1 0.0000
691 ABDOMINAL PAIN 4 0.0000
692 PALPITATIONS 2 0.0000
693 SURGERY 1 0.0000
694 FEELING ABNORMAL 4 0.0000
695 VERTIGO 1 0.0000
696 INJECTION SITE PAIN 5 0.0000
697 CHEST PAIN 3 0.0000
698 ANAEMIA 3 0.0000
699 GAIT DISTURBANCE 3 0.0000
700 INTENTIONAL OVERDOSE 1 0.0000
701 DEEP VEIN THROMBOSIS 1 0.0000
702 SWELLING FACE 1 0.0000
703 BLOOD CREATININE INCREASED 1 0.0000
704 INJECTION SITE REACTION 1 0.0000
705 INJURY 1 0.0000
706 SLEEP DISORDER 1 0.0000
707 SKIN BURNING SENSATION 1 0.0000
708 OVERDOSE 3 0.0000
709 EPISTAXIS 1 0.0000
710 HOT FLUSH 1 0.0000
711 CHRONIC KIDNEY DISEASE 1 0.0000
712 BACK PAIN 3 0.0000
713 ARTHRITIS 1 0.0000
714 INJECTION SITE BRUISING 1 0.0000
715 CARDIAC FAILURE CONGESTIVE 1 0.0000
716 INFLUENZA LIKE ILLNESS 1 0.0000
717 DRUG ABUSE 1 0.0000
718 DRUG WITHDRAWAL SYNDROME 1 0.0000
719 DEVICE ISSUE 1 0.0000
720 NO ADVERSE EVENT 2 0.0000
721 WEIGHT DECREASED 3 0.0000
722 BLOOD GLUCOSE INCREASED 2 0.0000
723 NEUROPATHY PERIPHERAL 1 0.0000
724 CONTUSION 1 0.0000
725 SYNCOPE 1 0.0000
726 ABDOMINAL PAIN UPPER 2 0.0000
727 ILLNESS 1 0.0000
728 ASTHMA 1 0.0000
729 EMOTIONAL DISTRESS 1 0.0000
730 INSOMNIA 2 0.0000
731 PRODUCT QUALITY ISSUE 1 0.0000
732 MEMORY IMPAIRMENT 1 0.0000
733 ARTHRALGIA 3 0.0000
734 MALAISE 3 0.0000
735 DRUG DEPENDENCE 1 0.0000
736 CEREBROVASCULAR ACCIDENT 1 0.0000
737 MYALGIA 1 0.0000
738 URINARY TRACT INFECTION 1 0.0000
739 MYOCARDIAL INFARCTION 1 0.0000
740 COVID-19 1 0.0000
741 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
742 FALL 1 0.0000